Identification of potential anticancer drug targets through the selection of growth-inhibitory genetic suppressor elements
- 1 July 2003
- journal article
- Published by Elsevier in Cancer Cell
- Vol. 4 (1) , 41-53
- https://doi.org/10.1016/s1535-6108(03)00169-7
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Src Family Kinases Phosphorylate Protein Kinase C δ on Tyrosine Residues and Modify the Neoplastic Phenotype of Skin KeratinocytesJournal of Biological Chemistry, 2002
- Cooperativity between the Ras-ERK and Rho-Rho Kinase Pathways in Urokinase-type Plasminogen Activator-stimulated Cell MigrationJournal of Biological Chemistry, 2002
- Initial sequencing and analysis of the human genomeNature, 2001
- Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4Oncogene, 2000
- Normal Development, Wound Healing, and Adenovirus Susceptibility in β5-Deficient MiceMolecular and Cellular Biology, 2000
- Isolation of growth suppressors from a cDNA expression libraryOncogene, 1998
- Defective induction but normal activation and function of p53 in mouse cells lacking poly-ADP-ribose polymeraseOncogene, 1997
- Inducible retroviral vectors regulated by lac repressor in mammalian cellsGene, 1996
- Differentiation induction in human breast tumor cells by okadaic acid and related inhibitors of protein phosphatases 1 and 2ABiochemical and Biophysical Research Communications, 1992
- 33258 Hoechst enhances the selectivity of the bromodeoxyuridine—light method of isolating conditional lethal mutantsExperimental Cell Research, 1977